Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Different definitions of the metabolic syndrome and risk for recurrent cardiovascular disease

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 492–493 (2006)Cite this article

boxed-textSaely CH et al. (2006) Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29: 901–907

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Reaven GM (2005) Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab 1: 9–14

    Article  CAS  Google Scholar 

  2. Kaplan NM (1996) The deadly quartet and the insulin resistance syndrome: an historical overview. Hypertens Res 19 (Suppl 1): S9–S11

    Article  Google Scholar 

  3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143–3421

  4. The International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf] (accessed 20 July 2006)

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Charles Howard Candler Professor of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA

    W Virgil Brown

Authors
  1. W Virgil Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Virgil Brown.

Ethics declarations

Competing interests

Dr Brown has been an advisor to or given lectures sponsored by Abbott, Astra-Zeneca, Bayer, Bristol-Myers/Squibb, Kos, Merck, Pfizer, Reliant, Sanofi-Aventis, Shering-Plough, and Takeda. During the past year, Emory University has received grants for research or CME programs from Abbott, Bristol-Myers, Merck, Astra-Zeneca, Kos, and Takeda.

Dr Brown owns no stock and holds no options in these companies or other pharmaceutical companies involved in lipid or vascular disease related business.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, W. Different definitions of the metabolic syndrome and risk for recurrent cardiovascular disease. Nat Rev Endocrinol 2, 492–493 (2006). https://doi.org/10.1038/ncpendmet0272

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0272

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing